$TRUMP THREATENS 200% TARIFFS ON PHARMA IMPORTS

What Happened:

During a Cabinet meeting, President Trump announced plans to impose 200% tariffs on pharmaceutical imports “very soon” if drug companies fail to bring manufacturing back to the U.S. A grace period of 12 to 18 months will be given.

Market Reaction:

Biotech ETFs jumped:

SPDR S&P Biotech +1.4%,

iShares Biotech +0.9%,

ProShares Ultra Nasdaq Biotech +1.8%

Signals strong push toward reshoring U.S. drug production.

What It Means:

Pharma giants like J&J, Eli Lilly, and AbbVie may scale up local operations.

Supply chains might face disruption, impacting global drug costs.

Coins to Watch:

BTC – could benefit as global economic uncertainty rises.

ETH – DeFi innovation could gain traction amid centralized disruption.

---

FOLLOW ❤️

#CryptoNews #TrumpTariffs #PharmaCrisis #BinanceSquare #InsidePro